PLN 50.9
(5.17%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | 69.31 Million PLN | -72.86% |
2022 | 44.77 Million PLN | 71.66% |
2021 | 26.08 Million PLN | 33.46% |
2020 | 19.54 Million PLN | 409.58% |
2019 | 3.83 Million PLN | -65.55% |
2018 | 11.13 Million PLN | 66.12% |
2017 | 6.7 Million PLN | 652.16% |
2016 | -1.21 Million PLN | -158.54% |
2015 | 2.07 Million PLN | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q1 | -3.06 Million PLN | -183.05% |
2024 Q2 | -6.29 Million PLN | -105.09% |
2023 Q2 | 5.38 Million PLN | 25.99% |
2023 Q1 | 4.27 Million PLN | -70.58% |
2023 Q4 | 3.69 Million PLN | 11.34% |
2023 Q3 | 3.31 Million PLN | -38.41% |
2023 FY | 12.15 Million PLN | -72.86% |
2022 Q2 | 7.65 Million PLN | -2.64% |
2022 FY | 44.77 Million PLN | 71.66% |
2022 Q4 | 14.53 Million PLN | -1.37% |
2022 Q3 | 14.73 Million PLN | 92.59% |
2022 Q1 | 7.85 Million PLN | 33.01% |
2021 FY | 26.08 Million PLN | 33.46% |
2021 Q2 | 2.94 Million PLN | -75.67% |
2021 Q1 | 12.1 Million PLN | 220.91% |
2021 Q3 | 5.12 Million PLN | 74.13% |
2021 Q4 | 5.9 Million PLN | 15.22% |
2020 Q1 | 4.48 Million PLN | -20.54% |
2020 Q2 | 5.48 Million PLN | 22.4% |
2020 FY | 19.54 Million PLN | 409.58% |
2020 Q4 | 3.77 Million PLN | -35.03% |
2020 Q3 | 5.8 Million PLN | 5.83% |
2019 Q2 | -187.58 Thousand PLN | -107.21% |
2019 Q1 | 2.6 Million PLN | 0.0% |
2019 FY | 3.83 Million PLN | -65.55% |
2019 Q4 | 5.63 Million PLN | 7375.04% |
2019 Q3 | -77.52 Thousand PLN | 58.67% |
2018 Q3 | 3.07 Million PLN | 0.0% |
2018 FY | 11.13 Million PLN | 66.12% |
2018 Q1 | 2.34 Million PLN | 0.0% |
2017 FY | 6.7 Million PLN | 652.16% |
2016 FY | -1.21 Million PLN | -158.54% |
2015 FY | 2.07 Million PLN | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
BioMaxima S.A. | 201 Thousand PLN | -34383.085% |
Scope Fluidics S.A. | -28.68 Million PLN | 341.645% |
Voxel S.A. | 112.71 Million PLN | 38.51% |